{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:21:44Z","timestamp":1792448504044,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:00:00Z","timestamp":1562803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mesenchymal stromal cells (MSCs) transplantation offers an attractive alternative in myocardial infarctive therapy. However, poor cell engraftment and survival limit their restorative capacity. C1q\/tumor necrosis factor-related protein-3 (CTRP3) inhibits reverse remodeling after myocardial infarction (MI) and was found to be secreted by MSCs in our preliminary experiments. We examined whether the overexpression of CTRP3 improved the survival of transplanted MSCs and augmented their efficacy on MI and whether silencing CTRP3 attenuated these effects. For gain-of-function analysis, MSCs overexpressing CTRP3 (LvC3-MSCs), control virus-transfected MSCs (LvNull-MSCs), MSCs alone, or phosphate-buffered saline (PBS) were injected into the peripheral areas of the infarction immediately after coronary artery ligation. For loss-of-function analysis, mice subjected to MI were randomized into groups and administered CTRP3-knockdown MSCs (LvshC3-MSCs), Lvshctrl-MSCs, MSCs, or PBS. Survival rates, cardiac function, and myocardial remodeling in mice were evaluated after 4 weeks. Injection of MSCs or LvNull-MSCs improved the left ventricular ejection fraction, inhibited cardiac fibrosis, and regulated cellular profiles of the infarction border zone 4 weeks after MI compared with those in the PBS group. Furthermore, overexpression of hCTRP3 promoted the efficacy of MSCs in the treatment of MI. However, knocking down CTRP3 impaired that. Coculture experiments confirmed that hCTRP3-enriched conditioned medium (CM) promoted MSCs migration and protected against H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>-induced cell damage. Conversely, CM from C3<jats:sup>\u2212\/\u2212<\/jats:sup> MSCs (CTRP3 knock out) significantly reduced the migration and antioxidative effects of MSCs. CTRP3 protein alone promoted MSCs proliferation and migration by upregulating matrix metalloproteinase 9 (MMP9) and protecting against oxidation by increasing superoxide dismutase 2 (SOD2) and metallothionein 1\/2 (MT1\/2) expression; and these effects were blocked by pretreatment with the extracellular signal-regulated kinase (ERK1\/2) inhibitor U0126. Overexpression of CTRP3 significantly improved the MSCs-based efficacy on MI by increasing cell survival and retention via a mechanism involving ERK1\/2-MMP9 and ERK1\/2-SOD2\/MT1\/2 signaling.<\/jats:p>","DOI":"10.1038\/s41419-019-1760-5","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T13:50:39Z","timestamp":1562853039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["C1q\/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction"],"prefix":"10.1038","volume":"10","author":[{"given":"Zhengbin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongxi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,11]]},"reference":[{"key":"1760_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin, E. J. et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 137, e67 (2018).","journal-title":"Circulation"},{"key":"1760_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.yjmcc.2006.07.023","volume":"41","author":"J Muller-Ehmsen","year":"2006","unstructured":"Muller-Ehmsen, J. et al. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J. Mol. Cell Cadiol. 41, 876 (2006).","journal-title":"J. Mol. Cell Cadiol."},{"key":"1760_CR3","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1161\/01.CIR.96.7.2414","volume":"96","author":"MF Hill","year":"1997","unstructured":"Hill, M. F. & Singal, P. K. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 96, 2414 (1997).","journal-title":"Circulation"},{"key":"1760_CR4","doi-asserted-by":"publisher","first-page":"2989076","DOI":"10.1155\/2016\/2989076","volume":"2016","author":"RA Denu","year":"2016","unstructured":"Denu, R. A. & Hematti, P. Effects of oxidative stress on mesenchymal stem cell biology. Oxid. Med. Cell Longev. 2016, 2989076 (2016).","journal-title":"Oxid. Med. Cell Longev."},{"key":"1760_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cardiores.2006.02.016","volume":"70","author":"SY Lim","year":"2006","unstructured":"Lim, S. Y. et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc. Res. 70, 530 (2006).","journal-title":"Cardiovasc. Res."},{"key":"1760_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1161\/CIRCRESAHA.113.300929","volume":"113","author":"WE Wang","year":"2013","unstructured":"Wang, W. E. et al. Prolyl hydroxylase domain protein 2 silencing enhances the survival and paracrine function of transplanted adipose-derived stem cells in infarcted myocardium. Circ. Res. 113, 288 (2013).","journal-title":"Circ. Res."},{"key":"1760_CR7","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1002\/stem.230","volume":"27","author":"X Wang","year":"2009","unstructured":"Wang, X. et al. Hsp20-engineered mesenchymal stem cells are resistant to oxidative stress via enhanced activation of Akt and increased secretion of growth factors. Stem Cells 27, 3021 (2009).","journal-title":"Stem Cells"},{"key":"1760_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.107","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. SRT1720 promotes survival of aged human mesenchymal stem cells via FAIM: a pharmacological strategy to improve stem cell-based therapy for rat myocardial infarction. Cell Death Dis. 8, e2731 (2017).","journal-title":"Cell Death Dis."},{"key":"1760_CR9","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1161\/CIRCULATIONAHA.112.099937","volume":"125","author":"W Yi","year":"2012","unstructured":"Yi, W. et al. C1q\/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation 125, 3159 (2012).","journal-title":"Circulation"},{"key":"1760_CR10","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00109-015-1309-8","volume":"93","author":"D Wu","year":"2015","unstructured":"Wu, D. et al. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation. J. Mol. Med. 93, 1311 (2015).","journal-title":"J. Mol. Med."},{"key":"1760_CR11","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.117.029557","volume":"136","author":"W Yan","year":"2017","unstructured":"Yan, W. et al. C1q\/tumor necrosis factor-related protein-9 regulates the fate of implanted mesenchymal stem cells and mobilizes their protective effects against ischemic heart injury via multiple novel signaling pathways. Circulation 136, 2162 (2017).","journal-title":"Circulation"},{"key":"1760_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nprot.2008.221","volume":"4","author":"M Soleimani","year":"2009","unstructured":"Soleimani, M. & Nadri, S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat. Protoc. 4, 102 (2009).","journal-title":"Nat. Protoc."},{"key":"1760_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00395-013-0333-5","volume":"108","author":"Z Zhang","year":"2013","unstructured":"Zhang, Z. et al. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K\/Akt and MEK\/ERK pathways. Basic Res. Cardiol. 108, 333 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"1760_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","volume":"107","author":"E Gao","year":"2010","unstructured":"Gao, E. et al. A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ. Res. 107, 1445 (2010).","journal-title":"Circ. Res."},{"key":"1760_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/01.HYP.0000176236.55322.18","volume":"46","author":"MK Rude","year":"2005","unstructured":"Rude, M. K. et al. Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes. Hypertension 46, 555 (2005).","journal-title":"Hypertension"},{"key":"1760_CR16","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1096\/fj.05-5211com","volume":"20","author":"M Gnecchi","year":"2006","unstructured":"Gnecchi, M. et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20, 661 (2006).","journal-title":"FASEB J."},{"key":"1760_CR17","doi-asserted-by":"publisher","first-page":"H233","DOI":"10.1152\/ajpheart.00457.2018","volume":"316","author":"Y He","year":"2019","unstructured":"He, Y. et al. Resistin promotes cardiac homing of mesenchymal stem cells and functional recovery after myocardial ischemia-reperfusion via the ERK1\/2-MMP-9 pathway. Am. J. Physiol. Heart. Circ. Physiol. 316, H233 (2019).","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"key":"1760_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.plipres.2016.10.001","volume":"64","author":"Y Yang","year":"2016","unstructured":"Yang, Y. et al. A brief glimpse at CTRP3 and CTRP9 in lipid metabolism and cardiovascular protection. Prog. Lipid Res. 64, 170 (2016).","journal-title":"Prog. Lipid Res."},{"key":"1760_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/cphy.c160044","volume":"7","author":"Y Li","year":"2017","unstructured":"Li, Y., Wright, G. L. & Peterson, J. M. C1q\/TNF-related protein 3 (CTRP3) function and regulation. Compr. Physiol. 7, 863 (2017).","journal-title":"Compr. Physiol."},{"key":"1760_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/CIRCRESAHA.117.306306","volume":"117","author":"C Sanina","year":"2015","unstructured":"Sanina, C. & Hare, J. M. Mesenchymal stem cells as a biological drug for heart disease: where are we with cardiac cell-based therapy? Circ. Res. 117, 229 (2015).","journal-title":"Circ. Res."},{"key":"1760_CR21","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1152\/physrev.00019.2015","volume":"96","author":"S Golpanian","year":"2016","unstructured":"Golpanian, S., Wolf, A., Hatzistergos, K. E. & Hare, J. M. Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiol. Rev. 96, 1127 (2016).","journal-title":"Physiol. Rev."},{"key":"1760_CR22","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7150\/thno.7976","volume":"5","author":"B Tao","year":"2015","unstructured":"Tao, B. et al. Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart. Theranostics 5, 196 (2015).","journal-title":"Theranostics"},{"key":"1760_CR23","doi-asserted-by":"publisher","first-page":"S220","DOI":"10.1161\/CIRCULATIONAHA.108.842302","volume":"120","author":"JA Dixon","year":"2009","unstructured":"Dixon, J. A. et al. Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 120, S220 (2009).","journal-title":"Circulation"},{"key":"1760_CR24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1172\/JCI200524408","volume":"115","author":"FJ Giordano","year":"2005","unstructured":"Giordano, F. J. Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115, 500 (2005).","journal-title":"J. Clin. Invest."},{"key":"1760_CR25","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1161\/ATVBAHA.111.224915","volume":"32","author":"K Konstantinidis","year":"2012","unstructured":"Konstantinidis, K., Whelan, R. S. & Kitsis, R. N. Mechanisms of cell death in heart disease. Arterioscler. Thromb. Vasc. Biol. 32, 1552 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1760_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.pneurobio.2016.06.006","volume":"157","author":"PR Ham","year":"2017","unstructured":"Ham, P. R. & Raju, R. Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog. Neurobiol. 157, 92 (2017).","journal-title":"Prog. Neurobiol."},{"key":"1760_CR27","doi-asserted-by":"publisher","first-page":"5504","DOI":"10.1111\/jcmm.13821","volume":"22","author":"DY Zhang","year":"2018","unstructured":"Zhang, D. Y. et al. Sirtuin3 protects aged human mesenchymal stem cells against oxidative stress and enhances efficacy of cell therapy for ischaemic heart diseases. J. Cell. Mol. Med. 22, 5504 (2018).","journal-title":"J. Cell. Mol. Med."},{"key":"1760_CR28","doi-asserted-by":"publisher","first-page":"W580","DOI":"10.1093\/nar\/gkv279","volume":"43","author":"W Li","year":"2015","unstructured":"Li, W. et al. The EMBL-EBI bioinformatics web and programmatic tools framework. Nucleic Acids Res. 43, W580 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1760_CR29","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","volume":"103","author":"M Gnecchi","year":"2008","unstructured":"Gnecchi, M., Zhang, Z., Ni, A. & Dzau, V. J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103, 1204 (2008).","journal-title":"Circ. Res."},{"key":"1760_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.yexcr.2016.03.024","volume":"344","author":"L Zhao","year":"2016","unstructured":"Zhao, L. et al. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction. Exp. Cell Res. 344, 30 (2016).","journal-title":"Exp. Cell Res."},{"key":"1760_CR31","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1074\/jbc.M007898200","volume":"276","author":"T Maeda","year":"2001","unstructured":"Maeda, T., Abe, M., Kurisu, K., Jikko, A. & Furukawa, S. Molecular cloning and characterization of a novel gene, CORS26, encoding a putative secretory protein and its possible involvement in skeletal development. J. Biol. Chem. 276, 3628 (2001).","journal-title":"J. Biol. Chem."},{"key":"1760_CR32","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1073\/pnas.0403760101","volume":"101","author":"GW Wong","year":"2004","unstructured":"Wong, G. W., Wang, J., Hug, C., Tsao, T. S. & Lodish, H. F. A family of Acrp30\/adiponectin structural and functional paralogs. Proc. Natl. Acad. Sci USA 101, 10302 (2004).","journal-title":"Proc. Natl. Acad. Sci USA"},{"key":"1760_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1475-2840-13-14","volume":"13","author":"KM Choi","year":"2014","unstructured":"Choi, K. M. et al. Implications of C1q\/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris. Cardiovasc. Diabetol. 13, 14 (2014).","journal-title":"Cardiovasc. Diabetol."},{"key":"1760_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s00125-017-4232-4","volume":"60","author":"ZG Ma","year":"2017","unstructured":"Ma, Z. G. et al. CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats. Diabetologia 60, 1126 (2017).","journal-title":"Diabetologia"},{"key":"1760_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.304668","volume":"116","author":"PJ Kim","year":"2015","unstructured":"Kim, P. J. et al. Direct evaluation of myocardial viability and stem cell engraftment demonstrates salvage of the injured myocardium. Circ. Res. 116, e40 (2015).","journal-title":"Circ. Res."},{"key":"1760_CR36","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/CIRCRESAHA.115.307516","volume":"118","author":"X Hu","year":"2016","unstructured":"Hu, X. et al. A large-scale investigation of hypoxia-preconditioned allogeneic mesenchymal stem cells for myocardial repair in nonhuman primates: paracrine activity without remuscularization. Circ. Res. 118, 970 (2016).","journal-title":"Circ. Res."},{"key":"1760_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05868-y","volume":"7","author":"F Riu","year":"2017","unstructured":"Riu, F. et al. The adipokine leptin modulates adventitial pericyte functions by autocrine and paracrine signalling. Sci. Rep. 7, 5443 (2017).","journal-title":"Sci. Rep."},{"key":"1760_CR38","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1002\/jcp.26493","volume":"233","author":"A Pelagalli","year":"2018","unstructured":"Pelagalli, A., Nardelli, A., Lucarelli, E., Zannetti, A. & Brunetti, A. Autocrine signals increase ovine mesenchymal stem cells migration through Aquaporin-1 and CXCR4 overexpression. J. Cell Physiol. 233, 6241 (2018).","journal-title":"J. Cell Physiol."},{"key":"1760_CR39","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1182\/blood-2004-11-4349","volume":"105","author":"A Kortesidis","year":"2005","unstructured":"Kortesidis, A. et al. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105, 3793 (2005).","journal-title":"Blood"},{"key":"1760_CR40","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2006.08.005","volume":"27","author":"EL Eskelinen","year":"2006","unstructured":"Eskelinen, E. L. Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy. Mol. Aspects. Med. 27, 495 (2006).","journal-title":"Mol. Aspects. Med."},{"key":"1760_CR41","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1462-5822.2000.00071.x","volume":"2","author":"PE Kima","year":"2000","unstructured":"Kima, P. E., Burleigh, B. & Andrews, N. W. Surface-targeted lysosomal membrane glycoprotein-1 (Lamp-1) enhances lysosome exocytosis and cell invasion by trypanosoma cruzi. Cell. Microbiol. 2, 477 (2000).","journal-title":"Cell. Microbiol."},{"key":"1760_CR42","volume":"11","author":"Y Li","year":"2016","unstructured":"Li, Y., Ozment, T., Wright, G. L. & Peterson, J. M. Identification of putative receptors for the novel adipokine CTRP3 using ligand-receptor capture technology. PLOS ONE. 11, e164593 (2016).","journal-title":"PLOS ONE."},{"key":"1760_CR43","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/JPER.17-0087","volume":"89","author":"R Kunimatsu","year":"2018","unstructured":"Kunimatsu, R. et al. The C-terminus of the amelogenin peptide influences the proliferation of human bone marrow mesenchymal stem cells. J. Periodontol. 89, 496 (2018).","journal-title":"J. Periodontol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1760-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1760-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1760-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:15:01Z","timestamp":1671210901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1760-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,11]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["1760"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1760-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,11]]},"assertion":[{"value":"14 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"530"}}